# Ascend Capital Group

> Ascend Capital Group is a VC fund in Singapore backing Mining and FinTech. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Singapore, Singapore
- Total investments: 3
- Last investment: Jan 2024
- Lead investor: 67%
- Last updated: Aug 2026
- Website: http://www.ascendcapitals.com

Ascend Capital Group is a VC fund in Singapore focused on Mining and FinTech. Ascend Capital Group creates and executes public and private capital investment strategies for its investors with superior returns through value-added principles of investment.

## Contacts

5 contacts available for Ascend Capital Group. Shizune tracks 1 team members at Ascend Capital Group. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ascend-capital-group?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Mining | 1 | 33% |
| FinTech | 1 | 33% |
| Mineral | 1 | 33% |
| Chemical | 1 | 33% |
| InsurTech | 1 | 33% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Private Equity | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Australia | 1 | 33% |
| Indonesia | 1 | 33% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric Parekh | Managing Director | 0 | https://shizune.co/investors/profile/eric-parekh |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| 5E Advanced Materials | 5E Advanced Materials is a boron and lithium solution company. They provide services due to the scarcity of resources and reliance on an unstable international supply. Their customers' inquiries are addressed through phone, email, and online applications. | $6.6M | Post-IPO Equity | Jan 19, 2024 | https://x.com/5EAMaterials |
| FUNDtastic | FUNDtastic is an online investment platform. Is an easy and safe way to buy and sell mutal funds, gold and other investment instruments. | $7.7M | Series A | Feb 22, 2021 | https://x.com/fundtastic_id |
| Prometheus Biosciences | Prometheus Biosciences, Inc., former Prometheus Laboratories, Inc., a specialty pharmaceutical company, engages in developing and commercializing novel pharmaceutical and diagnostic products to help physicians individualize patient care. It markets and promotes Entocort EC, a glucocorticosteroid, which is indicated for the induction and maintenanceof clinical remission in mild to moderately active Crohn's disease involving the ileum and/or the ascending colon. It has an agreement to acquire rights to LOTRONEX tablets, which is used in female patients with diarrhea-predominant irritable bowel syndrome; and an agreement to develop and commercialize COLAL-PRED, a development-stage product for the treatment of gastrointestinal diseases or other applications. The company also sells other branded drugs, including Imuran for use as an adjunct for the prevention of rejection in kidney transplantation and the management of active rheumatoid arthritis, Helidac Therapy for use together with an H2 antagonist for the eradication of helicobacter pylori bacteria, and Ridaura for the management of rheumatoid arthritis. In addition, Prometheus Laboratories sells a generic formulation of mercaptopurine, which is approved as maintenance therapy for acute lymphatic leukemia as part of a combination regimen through third-party distributors. Further, it provides diagnostic testing services, including specific immunoassays to detect and differentiate diseases, pharmacogenetic testing, and drug metabolite monitoring; and tests that assist physicians in using and monitoring thiopurine drugs and the detection, diagnosis, or treatment of celiac disease, lactose intolerance, and other related disorders. Prometheus Laboratories, Inc. was founded in 1995 and is headquartered in San Diego, California. | $130M | Private Equity | Nov 09, 2020 | https://www.prometheusbiosciences.com |

3 of 3 investments shown.

## Co-investors
- [5ECAP](https://shizune.co/investors/profile/5ecap) — VC Fund, 1 deal together
- [Ascend Global Investments](https://shizune.co/investors/profile/ascend-global-investments-llc) — VC Fund, 1 deal together
- [Cedars Sinai](https://shizune.co/investors/profile/cedars-sinai-medical-centerr) — VC Fund, 1 deal together
- [Cormorant Capital](https://shizune.co/investors/profile/cormorant-capital) — VC Fund, 1 deal together
- [Cowen Healthcare Investments](https://shizune.co/investors/profile/cowen-healthcare-investments) — VC Fund, 1 deal together
- [Eventide](https://shizune.co/investors/profile/eventide-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [MS&AD Ventures](https://shizune.co/investors/profile/ms-ad-ventures) — VC Fund
- [Anthemis](https://shizune.co/investors/profile/anthemis-group) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [AC Ventures](https://shizune.co/investors/profile/acventures) — VC Fund

## Featured in investor lists
- [InsurTech Investors in Indonesia](https://shizune.co/investors/insurtech-investors-indonesia)
- [InsurTech VC Funds in Indonesia](https://shizune.co/investors/insurtech-vc-funds-indonesia)

## FAQ

### What does Ascend Capital Group invest in?

Ascend Capital Group invests primarily in Mining, FinTech and Mineral startups, most often at Series A and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ascend Capital Group?

Public channels for Ascend Capital Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ascend Capital Group?

The team at Ascend Capital Group includes Eric Parekh (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co